Discover Genmab
Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.
How is it working with them?
FAQ – JobTeaser asks the questions for you
What makes your company a great place to work for young talents?
Genmab will answer the question soon
Is it possible to progress to a full-time position after an internship or apprenticeship?
Genmab will answer the question soon
Can students and recent graduates work remotely?
Genmab will answer the question soon
Do you have any particularly busy recruitment periods throughout the year?
Genmab will answer the question soon
Deep dive into their world
We are Genmab.
Creation year
1999
International presence
4 countries